Can Neurologists Predict Long-Term Disability Trajectories in Primary Progressive MS?September 30, 2016Multiple Sclerosis
Alemtuzumab, natalizumab found equally effective for relapsing-remitting MSSeptember 22, 2016Multiple Sclerosis
Ocrelizumab Increases Likelihood of No Evidence of Disease Progression September 20, 2016Multiple Sclerosis
Arbaclofen Extended-Release Tablets Are Effective for MS SpasticitySeptember 20, 2016Multiple Sclerosis
Siponimod curbs disability in secondary progressive multiple sclerosisSeptember 20, 2016Multiple Sclerosis
Durable Efficacy of Alemtuzumab: Five-Year Follow-Up of the CARE-MS StudiesSeptember 16, 2016Multiple Sclerosis
Does the EDSS Capture Cognitive Difficulties in Patients With MS? September 16, 2016Multiple Sclerosis
Can Neurologists Predict Long-Term Disability Trajectories in Primary Progressive MS?September 16, 2016Multiple Sclerosis
Telerehabilitation May Be As Effective As In-Person Rehabilitation in MSSeptember 15, 2016Multiple Sclerosis
Durable Efficacy of Cladribine Tablets After Conversion to Clinically Definite MSSeptember 15, 2016Multiple Sclerosis
Demyelinating Diseases Are Associated With Psychiatric Disorders in Children September 14, 2016Multiple Sclerosis
